Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathan Cooper-Knock

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Neurobiology of Aging|August 10, 2015
C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia populationNatalya Y Abramycheva, Elena V Lysogorskaia, Maria S Stepanova, et al.
Brain : a Journal of Neurology|February 28, 2012
Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72Johnathan Cooper-Knock, Christopher Hewitt, J Robin Highley, et al.
Neurobiology of Aging|April 17, 2013
Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeatAshley R Jones, Ione Woollacott, Aleksey Shatunov, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2021
Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severitySai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
BMC Medicine|March 5, 2026
Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosisElham Alhathli, Johnathan Cooper-Knock, Zain-Ul-Abideen Girach, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseasesMarcel Weinreich, Harry McDonough, Nancy Yacovzada, et al.
Cell Reports|December 2, 2020
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk GeneJohnathan Cooper-Knock, Sai Zhang, Kevin P Kenna, et al.
Elife|November 19, 2021
Enrichment of <i>SARM1</i> alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disordersJonathan Gilley, Oscar Jackson, Menelaos Pipis, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking <i>C9ORF72</i>-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Neuron|January 19, 2022
Genome-wide identification of the genetic basis of amyotrophic lateral sclerosisSai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Neurobiology of Aging|August 10, 2015
C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia populationNatalya Y Abramycheva, Elena V Lysogorskaia, Maria S Stepanova, et al.
Brain : a Journal of Neurology|February 28, 2012
Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72Johnathan Cooper-Knock, Christopher Hewitt, J Robin Highley, et al.
Neurobiology of Aging|April 17, 2013
Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeatAshley R Jones, Ione Woollacott, Aleksey Shatunov, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2021
Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severitySai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
BMC Medicine|March 5, 2026
Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosisElham Alhathli, Johnathan Cooper-Knock, Zain-Ul-Abideen Girach, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseasesMarcel Weinreich, Harry McDonough, Nancy Yacovzada, et al.
Cell Reports|December 2, 2020
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk GeneJohnathan Cooper-Knock, Sai Zhang, Kevin P Kenna, et al.
Elife|November 19, 2021
Enrichment of <i>SARM1</i> alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disordersJonathan Gilley, Oscar Jackson, Menelaos Pipis, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking <i>C9ORF72</i>-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Neuron|January 19, 2022
Genome-wide identification of the genetic basis of amyotrophic lateral sclerosisSai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
Pageof 11